The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nebl, G.
Right arrow Articles by Samstag, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nebl, G.
Right arrow Articles by Samstag, Y.
The Journal of Immunology, 1998, 161: 1803-1810.
Copyright © 1998 by The American Association of Immunologists

Cyclosporin A-Resistant Transactivation of the IL-2 Promoter Requires Activity of Okadaic Acid-Sensitive Serine/Threonine Phosphatases1

Gabriele Nebl2, Stefan C. Meuer and Yvonne Samstag

Institute for Immunology, Ruprecht-Karls-University, Heidelberg, Germany

Expression of the IL-2 gene requires activation of T cells through stimulation of the TCR and costimulation through accessory receptors. We have found recently that okadaic acid-sensitive Ser/Thr phosphatases are involved in a cyclosporin A-insensitive pathway that selectively transmits costimulatory signals. In this study, we analyzed whether activities of these phosphatases are necessary for the expression of the IL-2 gene. In both activated peripheral blood T lymphocytes and activated tumorigenic T cell lines, IL-2 gene expression was blocked at the transcriptional level by okadaic acid. The transcription factors active at the IL-2 promoter were differentially influenced: upon down-modulation of okadaic acid-sensitive phosphatases, transactivation by octamer, NF-{kappa}B, and NF of activated T cells proteins was abrogated, while transactivation by AP-1 proteins was even enhanced.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Martin, M. Potente, V. Janssens, D. Vertommen, J.-C. Twizere, M. H. Rider, J. Goris, S. Dimmeler, R. Kettmann, and F. Dequiedt
Protein phosphatase 2A controls the activity of histone deacetylase 7 during T cell apoptosis and angiogenesis
PNAS, March 25, 2008; 105(12): 4727 - 4732.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J.-W. Shui, M. C.-T. Hu, and T.-H. Tan
Conditional Knockout Mice Reveal an Essential Role of Protein Phosphatase 4 in Thymocyte Development and Pre-T-Cell Receptor Signaling
Mol. Cell. Biol., January 1, 2007; 27(1): 79 - 91.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. H. Wabnitz, G. Nebl, M. Klemke, A. J. Schroder, and Y. Samstag
Phosphatidylinositol 3-Kinase Functions as a Ras Effector in the Signaling Cascade That Regulates Dephosphorylation of the Actin-Remodeling Protein Cofilin after Costimulation of Untransformed Human T Lymphocytes
J. Immunol., February 1, 2006; 176(3): 1668 - 1674.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Madrenas, L. A. Chau, W. A. Teft, P. W. Wu, J. Jussif, M. Kasaian, B. M. Carreno, and V. Ling
Conversion of CTLA-4 from Inhibitor to Activator of T Cells with a Bispecific Tandem Single-Chain Fv Ligand
J. Immunol., May 15, 2004; 172(10): 5948 - 5956.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Smith, I. Collins, G. V. R. Chandramouli, W. G. Butscher, E. Zaitseva, W. J. Freebern, C. M. Haggerty, V. Doseeva, and K. Gardner
Targeting Combinatorial Transcriptional Complex Assembly at Specific Modules within the Interleukin-2 Promoter by the Immunosuppressant SB203580
J. Biol. Chem., October 17, 2003; 278(42): 41034 - 41046.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. L. Salazar Murphy and C. C. W. Hughes
Endothelial Cells Stimulate T Cell NFAT Nuclear Translocation in the Presence of Cyclosporin A: Involvement of the wnt/Glycogen Synthase Kinase-3{beta} Pathway
J. Immunol., October 1, 2002; 169(7): 3717 - 3725.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. H. Wang, R. A. Kirken, R. A. Erwin, C.-R. Yu, and W. L. Farrar
JAK3, STAT, and MAPK Signaling Pathways as Novel Molecular Targets for the Tyrphostin AG-490 Regulation of IL-2-Mediated T Cell Response
J. Immunol., April 1, 1999; 162(7): 3897 - 3904.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.